Načítá se...
A Long-Acting PYY(3–36) Analog Mediates Robust Anorectic Efficacy with Minimal Emesis in Nonhuman Primates
The gut hormone PYY(3–36) reduces food intake in humans and exhibits at least additive efficacy in combination with GLP-1. However, the utility of PYY analogs as anti-obesity agents has been severely limited by emesis and rapid proteolysis, a profile similarly observed with native PYY(3–36) in obese...
Uloženo v:
| Vydáno v: | Cell Metab |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6701930/ https://ncbi.nlm.nih.gov/pubmed/30773465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2019.01.017 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|